EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum 1H NMR-Based Untargeted Metabolomics for Noninvasive Early Detection of Breast Cancer

Akbar Ali iD, Tengku Ahmad Damitri Al Astani Tengku Din iD, Maulidiani Maulidiani, Heba Mohammed Arafat, Wan Faiziah Wan Abdul Rahman, Maya Mazuwin Yahya, Suhaini Kadiman, Ras Azira Binti Ramli, Wan Norlina Wan Azman

Journal of Proteome Research · 07.08.2026 · 25 (8) · 3909-3925

DOI: 10.1021/acs.jproteome.5c01124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Proteome Research, online erschienen am 15.07.2026. Verfasst von Akbar Ali und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Pathology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian16150, Kelantan, Malaysia. Hauptthemen laut MEDLINE: Metabolomics, Breast Neoplasms, Early Detection of Cancer, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: School of Medical Sciences, Universiti Sains Malaysia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer (BC) is the most common malignancy among women, and late-stage presentation remains common in Asia, highlighting the need for affordable and minimally invasive adjuncts to imaging. This study evaluated whether fasting serum 1H NMR metabolomics could distinguish Malaysian women with newly diagnosed treatment-naïve BC from healthy controls and identify perturbed metabolic pathways. After spectral quality control exclusion, 101 participants were analyzed (BC, n = 44; control, n = 57). PCA and oOPLS-DA showed group separation, and 14 metabolites were deferred significantly after false discovery rate correction. Endogenous metabolites evaluated in BC included 3-hydroxybutyrate, citrate, glutamine, malonate, phenylalanine, dimethyl sulfone, myo-inositol, and L-carnitine, and the levels of formate, tyrosine, histamine, and p-hydroxyphenylacetate were reduced. Acetylsalicylate and salicylate were classified as exogenous aspirin-related markers and were excluded from the endogenous biomarker panel. Pathway analysis indicated disruptions in the tricarboxylic acid (TCA) cycle, glyoxylate/dicarboxylate metabolism, butanoate metabolism, and amino acid pathways. Metabolite-based classifiers achieved 0.901 accuracy on an internal held-out test partition (AUC 0.942) and 0.902 ± 0.061 accuracy in repeated stratified 5-fold cross-validation. These internally validated findings define a BC-associated serum metabolomic signature in a Southeast Asian cohort and warrant independent external validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetabolomicsBreast NeoplasmsEarly Detection of CancerBiomarkers, TumorMetabolomeProton Magnetic Resonance SpectroscopyHumansFemaleMiddle AgedAdultFormates3-Hydroxybutyric AcidPhenylacetatesMalonatesMetabolic Networks and PathwaysGlutamine

Stichwörter der Autor:innen

1H NMR spectroscopybiomarkersbreast cancermachine learningserum metabolomics

Substanzen

Biomarkers, TumorFormates3-Hydroxybutyric AcidPhenylacetatesMalonatesGlutamine

Autor:innen und Institutionen

  • Department of Chemical Pathology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian16150, Kelantan, Malaysia.
  • Faculty of Science and Marine Environment, Universiti Malaysia Terengganu, Kuala Nerus21030, Terengganu, Malaysia.
  • Department of Pathology, School of Medical Science, Health Campus, Universiti Sains Malaysia, Kubang Kerian16150, Kelantan, Malaysia.
  • Department of Surgery, School of Medical Science, Health Campus, Universiti Sains Malaysia, Kubang Kerian16150, Kelantan, Malaysia, Maya Mazuwin Yahya.
  • Anesthesia and Intensive Care Unit, National Heart Institute, Kuala Lumpur50400, Malaysia.
  • Faculty of Medicine Universiti Sultan Zainal Abidin , Kuala Terengganu20400, Terengganu, Malaysia.

ORCID-Profile: Akbar Ali, Tengku Ahmad Damitri Al Astani Tengku Din

Förderung

  • School of Medical Sciences, Universiti Sains Malaysia

Zitieren

APA

Ali, A., Tengku Din, T. A. D. A. A., Maulidiani, M., Arafat, H. M., Abdul Rahman, W. F. W., Mazuwin Yahya, M., Kadiman, S., Ramli, R. A. B., & Wan Azman, W. N. (2026). Serum 1H NMR-Based Untargeted Metabolomics for Noninvasive Early Detection of Breast Cancer. Journal of Proteome Research, 25(8), 3909-3925. https://doi.org/10.1021/acs.jproteome.5c01124

Vancouver

Ali A, Tengku Din TADAA, Maulidiani M, Arafat HM, Abdul Rahman WFW, Mazuwin Yahya M, et al. Serum 1H NMR-Based Untargeted Metabolomics for Noninvasive Early Detection of Breast Cancer. Journal of Proteome Research. 2026;25(8):3909-3925. doi:10.1021/acs.jproteome.5c01124

BibTeX
@article{Ali2026,
  author = {Ali, Akbar and Tengku Din, Tengku Ahmad Damitri Al Astani and Maulidiani, Maulidiani and Arafat, Heba Mohammed and Abdul Rahman, Wan Faiziah Wan and Mazuwin Yahya, Maya and Kadiman, Suhaini and Ramli, Ras Azira Binti and Wan Azman, Wan Norlina},
  title = {Serum 1H NMR-Based Untargeted Metabolomics for Noninvasive Early Detection of Breast Cancer},
  journal = {Journal of Proteome Research},
  year = {2026},
  volume = {25},
  number = {8},
  pages = {3909--3925},
  doi = {10.1021/acs.jproteome.5c01124}
}
Kostenlos starten →